Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Mosaic ImmunoEngineering Inc. (CPMV) had Debt to Capital Ratio of -0.25 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.17M |
|
-- |
|
-- |
|
$0.15M |
|
$-0.15M |
|
$-0.02M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.15M |
|
$-0.15M |
|
7.24M |
|
7.24M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.06M |
|
-- |
|
-- |
|
$0.06M |
|
$5.77M |
|
$1.43M |
|
$1.43M |
|
$7.20M |
|
$-7.14M |
|
$-7.14M |
|
$-7.14M |
|
7.24M |
|
| Cash Flow Statement Financials | |
$-0.06M |
|
-- |
|
-- |
|
$0.12M |
|
$0.05M |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.25 |
-0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.41% |
|
2.41% |
|
-298.15% |
|
3.01% |
|
$-0.99 |
|
$-0.01 |
|
$-0.01 |
|